Background Past respiratory viral epidemics suggest that bacterial infections impact clinical
outcomes. There is minimal information on potential co-pathogens in patients with …

Purpose To investigate antimicrobial use and primary and nosocomial infections in
hospitalized COVID-19 patients to provide data for guidance of antimicrobial therapy …

Background Antibacterials may be initiated out of concern for bacterial coinfection in
coronavirus disease 2019 (COVID-19). We determined prevalence and predictors of empiric …

In a multicenter cohort of 963 adults hospitalized due to coronavirus disease 2019 (COVID-
19), 5% had a proven hospital-acquired infection (HAI) and 21% had a proven, probable, or …

Background Patients hospitalized with coronavirus disease 2019 (COVID-19) are at
increased risk of health care–associated infections (HAIs), especially with prolonged …

Background The prevalence of bacterial infection in patients with COVID-19 is low, however,
empiric antibiotic use is high. Risk stratification may be needed to minimize unnecessary …

Hospitalized patients with SARS-CoV-2 infection (COVID-19) often receive antibiotics for
suspected bacterial coinfection. We estimated the incidence of bacterial coinfection and …

Background Bacterial and viral infections can occur with SARS‐CoV‐2 infection, but
prevalence, risk factors, and associated clinical outcomes are not fully understood. Methods …

ABSTRACT COVID-19 is associated with prolonged hospitalization and a high risk of
intubation, which raises concern for bacterial coinfection and antimicrobial resistance …

Background Increased utilization of antimicrobial therapy has been observed during the
coronavirus disease 2019 pandemic. We evaluated hospital outcomes based on the …